31 – 40 of 132
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Pre-analytical protocol for measuring Alzheimer's disease biomarkers in fresh CSF
(
- Contribution to journal › Article
-
Mark
Blood and cerebrospinal fluid neurofilament light differentially detect neurodegeneration in early Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Quantification of total apolipoprotein e and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases
(
- Contribution to journal › Article
-
Mark
Biomarker profiling beyond amyloid and tau : cerebrospinal fluid markers, hippocampal atrophy, and memory change in cognitively unimpaired older adults
(
- Contribution to journal › Article
- 2019
-
Mark
Towards a unified protocol for handling of CSF before β-amyloid measurements
(
- Contribution to journal › Article
-
Mark
Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
(
- Contribution to journal › Article
-
Mark
Method comparison study of the Elecsys® β-Amyloid (1–42) CSF assay versus comparator assays and LC-MS/MS
(
- Contribution to journal › Article
-
Mark
Cisterna Magna Injection in Rats to Study Glymphatic Function
(
- Contribution to journal › Article
-
Mark
Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease : Cross-validation study of practical algorithms
(
- Contribution to journal › Article
-
Mark
PDGF-B Is Required for Development of the Glymphatic System
(
- Contribution to journal › Article